Sumatriptan, a serotonin <scp>5HT<sub>1B</sub></scp> receptor agonist, acutely reduces insulin secretion and sensitivity and glucose effectiveness in overweight humans: A double‐blinded placebo‐controlled cross‐over trial
Diabetes, obesity & metabolism/Diabetes, obesity and metabolism